Detailed answers about NEXCAPE PHARMACEUTICALS LTD, including incorporation, status, business activity, and accounts information.
When was NEXCAPE PHARMACEUTICALS LTD founded?
NEXCAPE PHARMACEUTICALS LTD was officially incorporated on 12 November 2012 and is registered under company number 08290141. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NEXCAPE PHARMACEUTICALS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NEXCAPE PHARMACEUTICALS LTD?
NEXCAPE PHARMACEUTICALS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NEXCAPE PHARMACEUTICALS LTD do?
NEXCAPE PHARMACEUTICALS LTD operates in the following sector: 46460 - Wholesale of pharmaceutical goods. This provides insight into the company's primary business activity and industry focus.
What is NEXCAPE PHARMACEUTICALS LTD's registered address?
The registered office address of NEXCAPE PHARMACEUTICALS LTD is 20-22 WENLOCK ROAD, LONDON, ENGLAND, N1 7GU. This is the official address filed with Companies House for legal and statutory correspondence.
Is NEXCAPE PHARMACEUTICALS LTD financially stable?
The most recent accounts for NEXCAPE PHARMACEUTICALS LTD were made up to 31 March 2025, filed as UNAUDITED ABRIDGED. Next accounts are due by 31 December 2026.
Does NEXCAPE PHARMACEUTICALS LTD have any charges or mortgages?
NEXCAPE PHARMACEUTICALS LTD has 1 registered charge, of which 1 is outstanding, 0 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.